Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001501436 | SCV001706249 | likely benign | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2022-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002405189 | SCV002706550 | uncertain significance | Cardiovascular phenotype | 2023-06-14 | criteria provided, single submitter | clinical testing | The c.1662A>G variant (also known as p.K554K),is located in coding exon 12 of the NEXN gene. This variant results from an A to G substitution at nucleotide position 1662. This nucleotide substitution does not change the lysine at codon 554. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice acceptor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |